Daunorubicin and activated partial thromboplastin time prolonged Patient Reports February 11, 2012

Daunorubicin Side Effects Report #4576707-2
Daunorubicin side effect was reported by a Pharmacist from on Nov 10, 2004. Female patient, 73 years of age, weighting 120.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, febrile neutropenia, sinus tachycardia. Daunorubicin dosage: 45MG/M2. During the same period patient was treated with CIPROFLOXACIN, SYNTHROID. Patient was hospitalized. Patient recovered.

Daunorubicin Side Effects Report #4578607-0
Daunorubicin side effect was reported by a Consumer or non-health professional from on Feb 08, 2005. Female patient, 73 years of age, weighting 119.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, blood bilirubin increased, cough, febrile neutropenia, sinus tachycardia. Daunorubicin dosage: 45 MG/M2 OTHER. During the same period patient was treated with CYTARABINE, CIPROFLOXACIN, SYNTHROID, CALTRATE PLUS, GLUCOSAMINE, ACTONEL. Patient was hospitalized. Patient recovered.

Daunorubicin Side Effects Report #4799935-X
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 12, 2005. Female patient, weighting 169.8 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, alpha haemolytic streptococcal infection, atrial fibrillation , blood bilirubin increased, blood fibrinogen increased, blood phosphorus increased, body temperature increased, brain natriuretic peptide increased, constipation . Daunorubicin dosage: unknown. During the same period patient was treated with VINCRISTINE SULPHATE, PREDNISONE, METHOTREXATE. Patient was hospitalized. Patient recovered.

Daunorubicin Side Effects Report #4799942-7
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 12, 2005. Female patient, weighting 169.8 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, alpha haemolytic streptococcal infection, atrial fibrillation , blood bilirubin increased, blood fibrinogen increased, blood phosphorus increased, body temperature increased, brain natriuretic peptide increased, constipation . Daunorubicin dosage: unknown. During the same period patient was treated with VINCRISTINE SULPHATE, PREDNISONE, METHOTREXATE. Patient was hospitalized. Patient recovered.


Daunorubicin Side Effects Report #4799946-4
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 12, 2005. Female patient, weighting 169.8 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, alpha haemolytic streptococcal infection, atrial fibrillation , blood bilirubin increased, blood fibrinogen increased, blood phosphorus increased, body temperature increased, brain natriuretic peptide increased, constipation . Daunorubicin dosage: unknown. During the same period patient was treated with VINCRISTINE SULPHATE, PREDNISONE, METHOTREXATE. Patient was hospitalized. Patient recovered.

Daunorubicin Side Effects Report #4840614-8
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 29, 2005. Female patient, weighting 153.2 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, blood fibrinogen decreased, prothrombin time prolonged, pulmonary embolism . Daunorubicin dosage: unknown. During the same period patient was treated with VINCRISTINE SULPHATE, METHOTREXATE, PREDNISONE. Patient recovered.

Daunorubicin Side Effects Report #5390181-8
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on July 16, 2007. Female patient, weighting 183.0 lb, was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, alanine aminotransferase increased, aspartate aminotransferase increased, aspergillosis, blood bilirubin increased, febrile neutropenia, fungaemia, hepatic function abnormal, hepatic steatosis. Daunorubicin dosage: 4 MG. During the same period patient was treated with DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Daunorubicin Side Effects Report #5400118-0
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on July 27, 2007. Female patient, weighting 183.0 lb, was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, acute lymphocytic leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, computerised tomogram abnormal, fungaemia, fungal infection , hepatic function abnormal. Daunorubicin dosage: 4 MG. During the same period patient was treated with DEXAMETHASONE, METHOTREXATE, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.